Papers
2
Total Citations
82
H-Index
2
About
Dr. Chunlin Tan is a leading urologic surgeon and researcher whose work is reshaping the surgical management of prostate and kidney cancers. His primary research focuses on the comparative effectiveness of robotic-assisted surgery versus traditional open approaches, with a particular emphasis on optimizing outcomes for complex renal tumors. Dr. Tan’s landmark 2023 systematic review and meta-analysis, which has garnered 70 citations, provides compelling evidence on the perioperative and functional advantages of robot-assisted radical prostatectomy over open surgery, establishing a critical benchmark for clinical decision-making. Further demonstrating his expertise in nephron-sparing surgery, Dr. Tan has conducted rigorous evidence-based analyses on robot-assisted partial nephrectomy for challenging tumor types—including hilar, endophytic, and cystic lesions. His work, cited 12 times, systematically evaluates how tumor complexity impacts surgical outcomes, offering vital guidance for surgeons treating these high-risk patients. By synthesizing high-quality data to clarify the benefits of minimally invasive techniques, Dr. Tan is directly influencing modern urologic oncology practice and improving patient recovery and quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2